Clinverse, Inc. Names Seasoned Industry Veteran as Chief Commercial Officer

Share Article

John Musante brings more than 25 years of pharmaceutical industry experience

News Image

Clinverse, Inc., provider of automated financial management technology solutions for clinical trials, announced today the addition of John Musante as Chief Commercial Officer. John brings more than 25 years of experience across industry sectors including health care, technology, and life sciences.

In this role, John is responsible for leading commercial efforts to strengthen Clinverse’s position as an industry leader. His appointment comes on the heels of a $9.1 million Series C round of funding, which is being used to further the company’s commitment to expanding its sales and marketing organization and to educating the marketplace about its best-in-class solution for automating the financial management of clinical trials.

Prior to joining Clinverse, John served as Senior Vice President, Business Development, at INC Research, where he led a team of account executives and participated in the structuring and execution of the company’s commercial strategy. He has previously held executive positions in both large and small pharmaceutical companies, such as GlaxoSmithKline and AcSentient, as well as at industry service providers that specialize in supply chain and clinical development, including Tompkins Associates.

“My time at a large, global CRO allowed me to realize the challenges and complexities of managing clinical trial finances,” said John. “Clinverse addresses those challenges, allowing sponsors and CROs to reduce workload and costs while improving transparency and control. It is exciting to join a company that helps bring predictability and stability to such a chaotic process.”

“John’s diverse background gives him a unique understanding of the industry and the challenges that our clients face in today’s environment as they look to improve efficiency and reduce costs,” said Denis Connaghan, Clinverse CEO. “We expect that experience to help him exceed client expectations while contributing to the company’s continued aggressive growth.”

About Clinverse, Inc.
Clinverse, Inc. architected the industry’s first automated financial management technology solutions for clinical trials. Powered by our secure technology platform, our solution standardizes clinical trial finance and manages millions of financial transactions across the globe, including clinical site payments. Used by leading BioPharma companies, our clients benefit from reduced workload, time, and costs gained through automation and unprecedented transparency and workflow. For more information, please visit http://www.clinverse.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Cassandra Zink

Jennifer Plumer
Visit website